← FDA DRUG APPROVALS

FDA ANDA · ANDA205566

FENOFIBRATE

Sponsor: GLENMARK PHARMS LTD

APPLICATION
ANDA205566
TYPE
ANDA
ORIGINAL APPROVAL
2017-04-07
LATEST ACTION
2021-06-03
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

FENOFIBRATE (MICRONIZED)Prescription
FENOFIBRATE 200MG · CAPSULE · ORAL
FENOFIBRATE (MICRONIZED)Prescription
FENOFIBRATE 67MG · CAPSULE · ORAL
FENOFIBRATE (MICRONIZED)Prescription
FENOFIBRATE 134MG · CAPSULE · ORAL

Approval history

2021-06-03Labeling · Supplement 5 · standardAP
2019-05-15Labeling · Supplement 3 · standardAP
2018-05-18Labeling · Supplement 2 · standardAP
2017-04-07UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →